Ionis Pharmaceuticals Inc (IONS)
43.10
+0.09
(+0.21%)
USD |
NASDAQ |
May 02, 16:00
43.11
+0.01
(+0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Shareholders Equity (Quarterly): 386.69M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 386.69M |
September 30, 2023 | 315.46M |
June 30, 2023 | 428.30M |
March 31, 2023 | 486.57M |
December 31, 2022 | 572.89M |
September 30, 2022 | 594.36M |
June 30, 2022 | 624.73M |
March 31, 2022 | 709.57M |
December 31, 2021 | 771.74M |
September 30, 2021 | 530.54M |
June 30, 2021 | 582.67M |
March 31, 2021 | 680.56M |
December 31, 2020 | 743.28M |
September 30, 2020 | 1.383B |
June 30, 2020 | 1.377B |
March 31, 2020 | 1.360B |
December 31, 2019 | 1.471B |
September 30, 2019 | 1.336B |
June 30, 2019 | 1.269B |
March 31, 2019 | 1.208B |
December 31, 2018 | 1.048B |
September 30, 2018 | 710.55M |
June 30, 2018 | 696.26M |
March 31, 2018 | 301.39M |
December 31, 2017 | 281.01M |
Date | Value |
---|---|
September 30, 2017 | 307.97M |
June 30, 2017 | 215.57M |
March 31, 2017 | 201.81M |
December 31, 2016 | 99.56M |
September 30, 2016 | 139.64M |
June 30, 2016 | 111.21M |
March 31, 2016 | 158.16M |
December 31, 2015 | 200.79M |
September 30, 2015 | 245.41M |
June 30, 2015 | 300.32M |
March 31, 2015 | 275.85M |
December 31, 2014 | 257.78M |
September 30, 2014 | 344.77M |
June 30, 2014 | 366.86M |
March 31, 2014 | 374.10M |
December 31, 2013 | 378.39M |
September 30, 2013 | 401.45M |
June 30, 2013 | 401.08M |
March 31, 2013 | 201.09M |
December 31, 2012 | 182.77M |
September 30, 2012 | 170.28M |
June 30, 2012 | 154.31M |
March 31, 2012 | 150.87M |
December 31, 2011 | 171.43M |
September 30, 2011 | 186.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
315.46M
Minimum
Sep 2023
1.471B
Maximum
Dec 2019
822.35M
Average
680.56M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 405.33M |
Viking Therapeutics Inc | 933.89M |
Alnylam Pharmaceuticals Inc | -220.64M |
Akero Therapeutics Inc | 535.31M |
89bio Inc | 536.31M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.990B |
Total Liabilities (Quarterly) | 2.603B |
Debt to Equity Ratio | 3.317 |
Current Ratio | 5.896 |
Net Debt Paydown Yield | -0.16% |